Measles Virus Genotypes Associated with SSPE
Direct Answer
SSPE is caused by wild-type measles virus strains across multiple genotypes, not by vaccine strains, with documented cases linked to genotypes C, D1, D4.2, D6, D7, F, G3, H1, and potentially others—essentially any wild-type measles genotype can cause SSPE, with the possible exception of genotype B3. 1, 2
Genotypes Documented in SSPE Cases
The following wild-type measles virus genotypes have been definitively identified in SSPE patients through molecular sequencing:
- Genotype C: Identified in patients who acquired measles infection in the 1950s 2
- Genotype D1: Found in patients infected during the 1960s and 1970s 2
- Genotype D4.2: Recently reported and noted as one of the most antigenically altered genotypes 3
- Genotype D6: Documented in a Canadian SSPE case with significant genetic divergence 4, 2
- Genotype D7: Identified in patients infected during the 1980s 2
- Genotype F: Associated with SSPE case SMa79 5
- Genotype G3: Documented in SSPE cases 5
- Genotype H1: Noted as one of the most antigenically altered genotypes 3
Critical Molecular Marker: The PEA Motif
A specific molecular signature in the matrix (M) protein—the PEA motif (residues P64, E89, and A209)—appears to be a consistent marker for wild-type measles viruses capable of causing SSPE. 1
Key Findings About the PEA Motif:
- All known SSPE viruses possess the PEA motif (P64, E89, A209) in their M proteins, particularly the A209 residue which is linked to increased viral spread 1
- Vaccine strains have different residues: Moraten vaccine strain has SKT (S64, K89, T209), while other vaccine strains may have PKT 1
- 9 of 10 sequenced wild-type genotypes have the PEA motif, with genotype B3 being the sole exception (having PET instead) 1
- Genotype B3 has never been reported to cause SSPE, suggesting the PEA motif may be essential for SSPE pathogenesis 1
Why Vaccine Strains Never Cause SSPE
Measles vaccine strains have never been documented to cause SSPE, and when SSPE occurs in previously vaccinated children, molecular evidence consistently shows wild-type virus, not vaccine strains. 6, 7, 2
- In a comprehensive UK study of 11 SSPE cases spanning 1965-2000, no vaccine strains were detected despite five patients having been previously immunized 2
- Children who developed SSPE after vaccination likely had unrecognized wild-type measles infection before vaccination 7, 3
- The molecular difference lies in the M protein structure: vaccine strains lack the PEA motif that characterizes SSPE-causing wild-type viruses 1
Antigenic Properties and Genotype Risk
SSPE-causing viruses show similar antigenic properties to currently circulating wild-type measles genotypes, and there is no evidence that antigenic drift or specific antigenic changes predispose certain genotypes to cause SSPE. 5
- Genotypes A, G3, and F (SSPE case SMa79) showed intact antigenic structure 5
- Genotypes D7 and F showed enhanced neutralization by monoclonal antibodies targeting antigenic site IIa 5
- The absence of correlation between antigenic changes and SSPE predisposition suggests antigenic drift is not the primary pathogenetic mechanism 5
Genetic Characteristics of SSPE Viruses
SSPE measles virus strains are defective and unable to produce progeny virions due to extensive mutations, particularly in the M gene, which shows characteristic biased hypermutations. 4, 2
- The M gene shows the greatest sequence divergence (17.6% nucleotide and 31% amino acid variation in one D6 strain) 4
- Premature termination codons in the M gene were detected in 5 of 11 SSPE sequences 2
- The L gene shows the least variation (1.3% nucleotide and 0.7% amino acid differences) 4
- Overall genome nucleotide variability compared to wild-type strains is approximately 3% 4
Clinical Implications
Any child who contracts wild-type measles infection is at risk for SSPE (approximately 4-11 per 100,000 measles cases), with highest risk in children infected before age 5 years. 6, 8